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abstract: Ectopic pregnancy (EP) remains a considerable cause of morbidity and occasional mortality. Currently, there is no reliable test
to differentiate ectopic from intrauterine gestation. We have previously used array technology to demonstrate that differences in gene
expression in decidualized endometrium from women with ectopic and intrauterine gestations could be used to identify candidate diagnostic
biomarkers for EP. The aim of this study was to further investigate the decidual gene with the highest fold increase in EP, cysteine-rich
secretory protein-3 (CRISP-3). Decidualized endometrium from gestation-matched women undergoing surgical termination of pregnancy
(n ¼ 8), evacuation of uterus for miscarriage (n ¼ 6) and surgery for EP (n ¼ 11) was subjected to quantitative RT–PCR, morphological
assessment, immunohistochemistry and western blot analysis. Sera were analysed for progesterone and human chorionic gonadotrophin
(hCG) levels. Immortalized endometrial epithelial cells were cultured with physiological concentrations of hCG. CRISP-3 mRNA and
protein expression were greater in endometrium from ectopic when compared with intrauterine pregnancies (P, 0.05). CRISP-3 protein
was localized to epithelium and granulocytes of endometrium. CRISP-3 serum concentrations were not different in women with ectopic
compared with intrauterine pregnancies. CRISP-3 expression in endometrium was not related to the degree of decidualization or
to serum progesterone levels. Endometrial CRISP-3 expression was inversely proportional to serum hCG concentrations (P, 0.001).
Stimulation of endometrial epithelial cells with hCG in vitro caused a reduction in CRISP-3 expression (P, 0.01). The measurement of
CRISP-3 in endometrium could provide an additional tool in the diagnosis of failing early pregnancy of unknown location. The absence of
a local reduction in expression of CRISP-3 in decidualized endometrium of women with EP may be due to reduced exposure to hCG
due to the ectopic location of the trophoblast.
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Introduction
Tubal ectopic pregnancy remains a common cause of morbidity and
mortality (Farquhar, 2005). In the UK, between 2003 and 2005,
early pregnancy bleeding was the third most common cause of
maternal death, and more than 60% of these cases were due to rup-
tured tubal ectopic pregnancies (Saving Mother’s Lives, 2008). In the
USA, ruptured tubal ectopic pregnancy remains the most common
cause of pregnancy-related death in the ﬁrst trimester (Mukul and
Teal, 2007). Unfortunately, our knowledge of the complex molecular
and cellular interactions that contribute to tubal implantation is limited.
Furthermore, despite the use of serial serum beta-human chorionic
gonadotrophin (hCG) concentrations and transvaginal
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ultrasonography, diagnosis remains difﬁcult (ASRM, 2006). Indeed,
tubal ectopic pregnancy is frequently not diagnosed, or misdiagnosed,
at the initial visit (Duncan et al., 1995; Robson and O’shea, 1996).
The development of a biomarker that can differentiate a tubal
ectopic implantation from an intrauterine implantation is therefore
important. In the pre-genomic era, a one-by-one scientiﬁc approach
has been unsuccessful in revealing markers that could be used as a
test for tubal ectopic pregnancy (Birkhahn et al., 2001; Wegner and
Mershon, 2001; Develioglu et al., 2002; Florio et al., 2007).
However, we have recently shown that high-density oligonucleotide
microarray analysis is helpful in identifying novel genes that are
altered during tubal implantation (Horne et al., 2008). Using this tech-
nology, we demonstrated that a secreted product, Activin B, from the
decidualized endometrium was a candidate biomarker for tubal
ectopic pregnancy (Horne et al., 2008).
During that study, the gene with the highest fold increase in the
decidualized endometrium of ectopic pregnancy, when compared
with that of intrauterine pregnancy (FC ¼ 13.10), was cysteine-rich
secretory protein 3 (CRISP-3). CRISP-3, which is also known as speciﬁc
granule protein of 28 kDa (SGP28), belongs to a family of CRISPs
characterized by their size (220–230 amino acids), their secretory
properties and a content of 16 highly conserved cysteine residues,
which form intra-molecular disulphide bond (Kjeldsen et al., 1996;
Gibbs and O’Bryan, 2007). In humans, CRISP-3 mRNA has been
detected at high concentrations in the salivary glands, pancreas and
prostate, and at lower levels in the epididymis, ovary, thymus and
colon (Kratzschmar et al., 1996). Furthermore, CRISP-3 is secreted
and can be detected in human tissue ﬂuids such as saliva, sweat,
blood and seminal plasma making it an ideal candidate biomarker
for pathophysiological conditions, such as ectopic pregnancy (Udby
et al., 2002a; Bjartell et al., 2006).
We hypothesized that, since CRISP-3 is secreted, if decidual CRISP-3
expression is higher in ectopic pregnancy, this could form the basis of a
novel test for tubal implantation. This study aimed to further investi-
gate CRISP-3 expression, localization and regulation in the decidualized
endometrium of women with tubal ectopic pregnancy. In addition we
aimed to use such analyses to inform us about the molecular regu-
lation of endometrial function during normal early pregnancy. Herein
we report the identiﬁcation, expression, localization, underlying bio-
logical regulation and serum concentrations of CRISP-3 in gestation-
matched women with tubal and intrauterine implantation.
Materials and Methods
Tissue collection
Ethical approval for this study was obtained from Lothian Research Ethics
Committee and informed written consent was obtained from all patients
before sample collection. First trimester decidualized endometrium was
obtained from gestation-matched women (age 18–45 years) undergoing
surgical termination of pregnancy (TOP, n ¼ 8, Group 1, mean gestation
58.7 days), surgical management of embryonic missed miscarriage (n ¼
6, Group 2, mean gestation 57.7 days) and surgical management of tubal
pregnancy (n ¼ 11, Group 3, mean gestation 58.1 days). None of the
women undergoing surgical management of tubal ectopic pregnancy pre-
sented acutely with hemodynamic shock, and all required serial serum
hCG and ultrasound monitoring prior to diagnosis. The decidualized endo-
metrium and trophoblast were obtained by suction curettage from Groups
1 and 2. The decidualized endometrium was obtained by suction endo-
metrial biopsy (PipelleTM, Eurosurgical Ltd, Cranleigh, UK) from Group
3. The decidualized endometrium was isolated from the trophoblast
macroscopically and was (i) immersed in RNAlaterTM (Ambion, TX,
USA) at 48C overnight then ﬂash frozen at 2708C; and (ii) ﬁxed in 10%
neutral buffered formalin overnight at 48C, stored in 70% ethanol and
wax embedded for staining with haematoxylin and eosin and immunohis-
tochemistry. The presence of trophoblast was ruled out morphologically
and by using immunohistochemical staining for cytokeratin as described
previously (Ball et al., 2006).
RNA extraction
Total RNA was extracted from the decidualized endometrium and cell
culture experiments as detailed in the manufacturers’ protocol (Qiagen,
West Sussex, UK). The concentration and quality of the extracted RNA
was assessed using an Agilent bioanalyser and quantiﬁed using an
ND-1000 spectrophotometer (Nanodrop technologies, DE, USA). All
samples were standardized for quality control and assigned an RNA integ-
rity number (RIN). RNA samples were considered to be of good quality
when a mean RIN value of 7.5 was obtained (Schroeder et al., 2006).
Microarray analysis
The conduct and robust standardization and assessment of the microarray
study that informed this study have been reported previously (Horne et al.,
2008). The microarray analysis involved 25 samples. Gene lists were
created using a fold change threshold of .2 and a corrected P-value of
,0.05, and CRISP-3 had the highest fold change in ectopic pregnancy
(13.10).
Quantitative RT–PCR
After DNAse treatment, using RQ1 DNase (Promega, Southampton, UK)
the RNA was reverse transcribed into cDNA using random hexamers
(Applied Biosystems, Foster City, CA, USA). Taqman Quantitative RT–
PCR was then used to measure gene levels in all 25 samples. Applied Bio-
systems pre-validated ‘assay-on-demand’ speciﬁc primers and probes
were used for analysis of tissue samples. cDNA from cell culture exper-
iments was assayed for CRISP-3 using validated primers and the Universal
Probe Library (www.universalprobelibrary.com, Roche Diagnostics,
Germany). All sample reactions were performed in triplicate. Using the
2-DDCt method, CRISP-3 mRNA expression results were normalized
against ribosomal 18S internal control (Applied Biosystems) and expressed
as the fold-change when compared with controls (TOP sample group or
untreated control).
Immunohistochemistry
Brieﬂy, immunolocalization of CRISP-3 was carried out using an anti-human
CRISP-3 monoclonal antibody in all 25 samples (MAB23971, R&D Systems,
Minneapolis, USA). In order to perform the experiment in a controlled
and easily repeatable manner, the Bond-X automated immunostaining
machine (Vision Biosystems, Newcastle, UK) was utilized. Parafﬁn sections
of uterine decidua (5 mm) were cut, dewaxed, rehydrated and subjected
to antigen retrieval in Antigen Unmasking Solution (Vector Laboratories,
Burlingame, CA, USA) for 15 min in the microwave before being placed
on the Bond-X machine. This method on the Bond-X automated
machine utilizes a speciﬁc polymer high-contrast program (Bond Reﬁne
Polymer detection kit). Slides were peroxidase blocked for 5 min, incu-
bated for 3 h with the primary antibody at 2.5 mg/ml in the Bond
diluent supplied and then incubated with the post-primary reagent for
8 min. To conﬁrm antibody speciﬁcity, control sections were incubated
with diluent alone or with non-speciﬁc mouse immunoglobulins, diluted
288 Horne et al.
to the same concentration as primary antibody in supplied diluent. Pros-
tate was used as a positive control (Udby et al., 2005). Sections were
then incubated with the polymer reagent for 8 min to increase sensitivity
of detection prior to DAB detection for 10 min. Sections were counter-
stained in haematoxylin for 5 min. Slides were then removed from the
machine and dehydrated and mounted using Pertex. The localization of
CRISP-3 was assessed by two independent observers blinded to tissue
identity, and it was consistent throughout all samples.
Western blot analysis
Total protein from all 25 decidualized endometrial biopsies was prepared
by homogenization (TissueLyser, Qiagen, UK) of RNALaterTM-treated
frozen tissue in buffer (1% Triton X, 0.1% SDS, 0.5% deoxycholactic
acid, 0.15 M NaCl, 0.02 M Tris) containing a protease inhibitor cocktail
(Complete, Roche Diagnostics, Mannheim, Germany). The proteins in
the supernatants were measured by the method of Bradford (Schleicher
and Wieland, 1978) adapted for use on a Cobas Fara Centrifugal Analyser
(Roche Diagnostics). Protein samples (20 mg) were run on 4–12% Novex
bis-tris gels in NuPAGE MOPS SDS buffer (Invitrogen, CA, USA). Proteins
were transferred onto a PVDF membrane (Immobilon-P, Millipore, MA,
USA) in Tris/glycine/methanol. After blocking in 5% skimmed milk/PBS
for 1 h, the membrane was washed with 0.5% BSA/PBS. The membrane
was incubated overnight at 48C with polyclonal rabbit anti-CRISP-3 IgG
(1 mg/ml) in 0.5% BSA/PBS (or CRISP-3 monoclonal antibody, R&D
Systems, Minneapolis, USA). Immunoblotting for b-actin (Abcam, Cam-
bridge, UK) was used as a comparative control between the samples.
After washes in 0.5% BSA/PBS, incubation with anti-rabbit HRP antibody
(A1949, Sigma, Dorset, UK) followed for 1 h at room temperature. The
membrane was washed as before, incubated with HRP substrate solution
(Immobilon Western, Millipore, MA, USA) for 5 min and exposed to
Amersham Hyperﬁlm ECL (GE Healthcare, Buckinghamshire, UK).
Images were also captured digitally using the VersaDoc Imaging System
(BioRad, CA, USA) and band density was assessed and corrected for
b-actin density on a Photoshop CS2 platform (Adobe, CA, USA).
Serum assays
Serum progesterone and hCG concentrations were measured using a stan-
dard radioimmunoassay in all 25 women (Corker and Davidson, 1978).
The concentration of CRISP-3 in serum samples was measured by a speciﬁc
in-house research ELISA similar to the method reported previously (Udby
et al., 2002a), except that recently developed rabbit anti-CRISP antibodies
raised against native human CRISP-3 from granulocytes were used for
capture and detection, and denaturation of samples was omitted. Native
CRISP-3 puriﬁed from human granulocytes was used as standard. The
average intra-assay coefﬁcient of variation was 2.7%, and the average inter-
assay coefﬁcients of variation were 6.6% (assays from same day) and 9.7%
(assays from different days) (Udby et al., 2002a).
Morphological analysis of sections
The samples of decidualized endometrium were classiﬁed blindly by a sub-
specialist gynaecological pathologist according to the degree of endo-
metrial change, as described previously (Horne et al., 2008). In short,
secretory transformation of the glandular epithelium (absent/early, high
and exhausted) and stromal differentiation (non-decidualized, pre-
decidual, conﬂuent decidual change) were scored as follows: samples
with exhausted glandular transformation with conﬂuent stromal deciduali-
zation were classed overall as decidualized (þ), those with absent/early
secretory transformation and non-decidual stroma were classiﬁed as
decidualized (2) and other samples were classiﬁed as decidualized
(þ/2).
Cell culture
The immortalized endometrial epithelial cell line (hTERT-EEpC)
(Hombach-Klonisch et al., 2005) was maintained in HAM’s F-10 media
with L-glutamine supplemented with insulin, transferrin, selenium (ITS)
(Lonza, MD, USA) and 10% foetal bovine serum (Sigma, MO, USA).
Cells were starved of serum for 24 h prior to treatments and for the dur-
ation of the experiments. The experiments were performed in triplicate.
The cells were treated with concentrations of hCG (PregnylTM, Organon
Laboratories, Cambridge, UK) mimicking concentrations that the maternal
epithelia adjacent to an implanting embryo is likely to be exposed. These
concentrations were modelled on those used in a previously published
study (Nakayama et al., 2003). In this study, the authors based their
assumptions on the fact that, in pregnant women, 6–12 days after ovu-
lation, the ﬁrst sign of pregnancy is a urinary hCG concentration of
greater than 0.325 mIU/ml on the day of blastocyst implantation. As the
concentration of hCG in the urine and plasma is similar, and the plasma
volume of a 50 kg woman is 1900 ml, the total amount of hCG is calcu-
lated to be 617.5 mIU (¼0.325 mIU/ml  1900 ml). Estimating that the
local volume surrounding the blastocyst in the fallopian tube ranges from
1 to 10 ml, the intraluminal concentration of hCG around the blastocyst
is estimated to be approximately 61.8 IU/ml. Therefore, in our study,
we used concentrations of 10 and 100 IU/ml.
Statistical analysis
All data were assessed for normality of distribution using a computer pro-
gramme (Prism 4; Graphpad Software, CA, USA). Where the data were
normally distributed, three groups were analysed by ANOVA with Bonfer-
roni pairwise comparisons. Two groups were analysed using a t-test.
Where the data were not normally distributed, Kruskal–Wallis testing
with Dunn’s pairwise comparisons was used to compare three groups.
Chi-squared test was used to compare proportions, and Spearman (non-
parametric) or Pearson (parametric) coefﬁcients were used to assess
linear correlations. The statistical test used is given in the text and ﬁgure
legend and signiﬁcance was at the P, 0.05 level.
Results
CRISP-3 mRNA is increased in decidualized
endometrium from tubal ectopic compared
with intrauterine pregnancies
A previously published comparison of gene expression in the decidua-
lized endometrium from women with intrauterine (n ¼ 14) and tubal
pregnancies (n ¼ 11) revealed that of the 669 genes that were differ-
entially expressed (FC .+2, P, 0.05) (Horne et al., 2008), CRISP-3
was up-regulated in the women with tubal ectopic pregnancies with
the highest fold increase (FC ¼ 13.10). Quantitive RT–PCR con-
ﬁrmed its increased expression in the decidualized endometrium
from tubal pregnancies when compared with both miscarriage (P,
0.01) and TOP (P, 0.01) groups (Fig. 1).
CRISP-3 protein is immunolocalized to the
epithelium and granulocytes in decidualized
endometrium
In order to further investigate CRISP-3 in the decidualized endome-
trium, it was localized using immunohistochemistry. Speciﬁc
immuno-staining for CRISP-3 could be detected in the glandular
epithelium, secreted within the glands (Fig. 2A–C) and in the
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granulocytes of the decidualized endometrium (Fig. 2D). This localiz-
ation pattern was consistent in all the decidual samples.
CRISP-3 protein is increased in decidualized
endometrium from tubal ectopic compared
with intrauterine pregnancies
Western blot analysis of decidual biopsies from patients with tubal
ectopic (n ¼ 11), miscarriages (n ¼ 6) and viable pregnancies (n ¼
8) revealed bands of 29 and 27 kDa corresponding to N-glycosylated
and non-glycoslyated CRISP-3 (Udby et al., 2005) (Fig. 3). Glycosylated
CRISP-3 was increased in the decidualized endometrium from tubal
ectopic pregnancy when compared with that from miscarriages and
viable pregnancies (Fig. 3).
CRISP-3 serum concentrations are similar
in women with tubal ectopic compared
with intrauterine pregnancies
As CRISP-3 is a secreted protein that is increased in the decidualized
endometrium of ectopic pregnancy, serum concentrations were ana-
lysed to determine if these mirrored endometrial expression. Serum
samples from patients with tubal ectopic pregnancies (n ¼ 11), miscar-
riages (n ¼ 6) and viable pregnancies (n ¼ 8) were assayed for CRISP-3
protein. There were no signiﬁcant differences in measured CRISP-3
concentrations (Fig. 4).
Figure 3 Representative western blot analysis of CRISP-3 protein in
uterine decidua.Western blot analysis revealed bands of 29 and
27 kDa corresponding to N-glycosylated and non-glycoslyated
CRISP-3. Miscarriage and TOP groups were combined as they
showed a similar pattern. Glycosylated CRISP-3 was increased in the
decidualized endometrium from tubal ectopic pregnancy when com-
pared with that from intrauterine pregnancies (P, 0.05; t-test).
Figure 4 Serum CRISP-3 concentrations.
Serum samples from patients with tubal ectopic pregnancies (n ¼ 11), miscar-
riages (n ¼ 6) and viable pregnancies (n ¼ 8) were assayed for CRISP-3 protein.
There were no signiﬁcant differences in measured CRISP-3 concentrations
(P . 0.05; ANOVA).
Figure 2 Immunohistochemistry for CRISP-3 in a representative
biopsy of decidualized endometrium from a woman with a tubal
ectopic pregnancy.
Speciﬁc immuno-staining for CRISP-3 in all 25 samples was similar and could be
detected in the glandular epithelium (A–C), secreted within the glands (A–C)
and in the granulocytes of the decidualized endometrium (D). Scale
bar ¼ 50 mm.
Figure 1 Expression of CRISP-3 mRNA in uterine decidua; CRISP-3
is differentially expressed.
It is increased in women with tubal ectopic pregnancy (Ectopic) when com-
pared with that of women undergoing surgical management of miscarriage
(Misc) (P, 0.01; Kruskal–Wallis) and surgical termination of pregnancy
(TOP) (P, 0.01; Kruskal–Wallis).
290 Horne et al.
CRISP-3 expression is not related to the
morphology of the decidualized
endometrium
As the decidualization of endometrium is different in the tubal ectopic,
miscarriage and viable pregnancy groups (Horne et al., 2008), the
relationship of CRISP-3 expression to decidual morphology was inves-
tigated. As previously demonstrated (Horne et al., 2008), in decidua-
lized endometrium from women with tubal ectopic pregnancies, the
glandular compartment (P, 0.05) showed a lesser degree of
secretory transformation and the stromal compartment (P, 0.05)
showed less decidualization when compared with intrauterine preg-
nancies (data not shown). When the samples were stratiﬁed based
on the overall degree of morphological decidualization, there was
however no clear correlation with CRISP-3 mRNA expression
(Fig. 5A) or serum concentrations (data not shown).
CRISP-3 mRNA expression is not related to
serum progesterone, but is inversely
proportional to serum hCG concentrations
As the degree of decidualization did not explain the observed differ-
ences in CRISP-3, its expression was investigated in relation to serum
progesterone and hCG concentrations (Fig. 5B and C, respectively).
There was no clear correlation between CRISP-3 mRNA expression
and serum progesterone (P. 0.05; Fig. 5B). However, when the
samples were analysed according to serum hCG, there was a
marked correlation with CRISP-3. Expression of CRISP-3 mRNA in
decidualized endometrium was inversely proportional to serum hCG
(P ¼ 0.0006; r ¼ 20.64; Fig. 5C).
hCG regulates CRISP-3 mRNA expression
in endometrial epithelial cells in vitro
As endometrial epithelial CRISP-3 mRNA expression was inversely
related to serum hCG concentrations in vivo, we hypothesized that
hCG could inhibit CRISP-3 epithelial expression. We therefore
assessed the effect of hCG treatment on CRISP-3 expression in endo-
metrial epithelial cells in vitro. At both 6 and 24 h, hCG treatment of
the cell line was associated with a dose-dependent decrease in endo-
metrial epithelial CRISP-3 mRNA expression (P, 0.01; Fig. 6).
Discussion
This study demonstrates a clear difference between the decidualized
endometrium of tubal ectopic and intrauterine pregnancies of similar
gestational ages, that may be reﬂected by an alteration in endometrial
secretory function. We have shown that decidual expression of
CRISP-3 is increased in tubal ectopic pregnancies when compared
with intrauterine pregnancies. In addition, the expression of CRISP-3
mRNA in the decidualized endometrium appears to be negatively
regulated by hCG. These data suggest that during early intrauterine
pregnancy, endometrial CRISP-3 expression may be inhibited by hCG
and that this does not occur to the same degree in tubal ectopic
pregnancy.
Disappointingly, although we demonstrated increased CRISP-3
mRNA and protein expression in the decidualized endometrium of
women with tubal ectopic pregnancies, we were unable to replicate
this ﬁnding in matched serum samples. As other organs and tissue
types, such as the salivary glands and pancreas, can contribute to
the blood level of CRISP-3, the total endometrial impact may be
low. The determination of CRISP-3 concentration in serial samples
across the menstrual cycle and after hysterectomy may address this
issue in more detail. At present, this study was not able to demon-
strate a role for CRISP-3 as a serum biomarker. However, it may be
that further assay reﬁnements would increase the sensitivity and
Figure 5 Association between the degree of morphological decid-
ualization, serum progesterone and hCG concentrations and the
decidual CRISP-3 mRNA expression. There was no signiﬁcant associ-
ation between the degree of morphological decidualization and
CRISP-3 mRNA expression (A) (P. 0.05; Kruskal–Wallis). There
was no clear association between CRISP-3 mRNA expression and
serum progesterone (P. 0.05; Spearman Rank Correlation) (B).
Expression of CRISP-3 mRNA in decidualized endometrium was inver-
sely proportional to serum hCG (P ¼ 0.0006; r ¼ 20.64) (C).
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speciﬁcity of the assay and CRISP-3 remains a possible candidate for a
biomarker in the future.
If there are no useful differences in serum CRISP-3 concentrations, it
remains possible that CRISP-3 could function as a biomarker in other
instances. For example, the rapid measurement of CRISP-3 in a small
biopsy of the uterine decidua could provide the clinical pathologist
with an additional means of diagnosing ectopic pregnancy in any
woman with a failing early pregnancy of unknown location. The use
of outpatient endometrial sampling in the rapid assessment of preg-
nancy location requires further study.
However, the endometrium in early pregnancy does express and
secrete CRISP-3 and the difference between intrauterine and tubal ges-
tation suggests that this expression is regulated. However, its role
within the human decidualized endometrium is not yet clear. It has
been suggested that CRISP-3 may have a role in the human innate
immune defence system. It is likely that the poorly understood
innate immune mechanisms and their involvement during implantation
have roles in facilitating successful human fertility. The role for CRISP-3
in human innate immune defence is supported by the expression of
CRISP-3 in neutrophils and in exocrine glands, and sequence similarities
with ‘pathogenesis-related proteins’, involved in plant anti-microbial
defence (Stintzi et al., 1993; Udby et al., 2002a). Certainly in normal
early pregnancy, it appears that there is lower endometrial CRISP-3
expression. This has clear parallels with the decidual expression of
another key mediator of the innate immune system. Secretory leuco-
cyte protease inhibitor is also relatively increased in the decidualized
endometrium of women with tubal ectopic pregnancies when com-
pared with those with intrauterine implantation (Dalgetty et al.,
2008). Together, these ﬁndings suggest that the endometrium has
an innate immunity that is locally regulated during early pregnancy.
It is possible that CRISP-3 has a role in endometrial tissue remodel-
ling as it is localized to speciﬁc and gelatinase-containing granules in
human neutrophils. This suggests a matrix degradative role, as these
granules are partially exocytosed during neutrophil migration and
inﬂammation (Udby et al., 2002b). In addition, CRISP-3 appears to
be up-regulated in chronic pancreatitis (Friess et al., 2001), further
supporting a role for CRISP-3 in localized tissue inﬂammatory and
immune response. Although there are clear morphological and func-
tional changes in the endometrium across the menstrual cycle, the
ontogeny of CRISP-3 expression is unclear. Further work therefore
needs to be done to investigate CRISP-3 expression in the endome-
trium and its role across the menstrual cycle and at the time of
implantation.
Whatever the role of CRISP-3 at the time of implantation, it is clear
that endometrial expression in early gestation is higher in tubal ectopic
pregnancy. The most obvious difference in the decidualized endome-
trium from the tubal pregnancy compared with the intrauterine groups
is the absence of a local trophoblast. The trophoblast has important
effects on the endometrium. Indeed, the effect of pregnancy on the
endometrium using the model of ectopic pregnancy has been
studied in another microarray study, demonstrating effects on the
complement and coagulation cascade, phospholid degradation, glyco-
sphingolipid biosynthesis, retinol metabolism, antigen presentation
pathway, glycosphingolipid biosynthesis and O-glycan biosynthesis
(Savaris et al., 2008). Recent in-vitro studies, also using a functional
genomics approach, have shown that conditioned media from tropho-
blast alter the local immune environment of the uterine decidua to
facilitate embryo implantation by causing a signiﬁcant induction of
pro-inﬂammatory cytokines and cells (Hess et al., 2007). This suggests
that differences between decidualized endometrium in ectopic and
intrauterine gestations may be the result of local trophoblast products.
In order to investigate why CRISP-3 was increased in the decidua of
ectopic pregnancies, we analysed whether the variation in CRISP-3
expression correlated with local and systemic variables in early preg-
nancy. The ﬁrst strategy was to examine whether it changed during
decidualization. The endometrium of ectopic pregnancies is less decid-
ualized than that of intrauterine pregnancies (Horne et al., 2008).
Unlike Activin B, which appears to be a decidual-related marker of
ectopic pregnancy (Horne et al., 2008), CRISP-3 expression is not
related to the degree of decidualization. As progesterone concen-
trations tend to be lower in ectopic pregnancy, we also assessed
whether progesterone concentrations were related to CRISP-3
expression and found no relationship between serum progesterone
and decidual CRISP-3 expression. This negative ﬁnding is perhaps
not surprising as progesterone receptors disappear from the endo-
metrial glands during the secretory phase (Koh et al., 1995) of the
cycle.
We found a highly signiﬁcant negative correlation between decidual
CRISP-3 expression and serum hCG concentrations. During the peri-
implantation period of pregnancy in primates, hCG is the ﬁrst clear
signal of the trophoblast’s presence and viability (Hearn et al.,
1988). Indeed, primate studies have shown that hCG induces altera-
tions in the endometrial expression of genes that regulate the
Figure 6 Regulation of endometrial epithelial CRISP-3 expression
in vitro.
At both 6 and 24 h, hCG treatment (100 IU/ml) was associated with a dose
dependent decrease in endometrial CRISP-3 mRNA expression (n ¼ 3)
(P, 0.01; ANOVA).
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modulation of the immune response around the implanting tropho-
blast (Sherwin et al., 2007). We realize the limitations our in-vitro
experimentation with hCG and short-term culture but, together
with our in-vivo observations, our ﬁndings suggest that CRISP-3 may
be an endometrial gene that can be regulated by hCG during early
pregnancy. It is therefore suggested that with tubal implantation, the
absence of a local reduction in the expression of CRISP-3 in the decid-
ualized endometrium of women with tubal ectopic pregnancy may be
due to the impaired production, or local effect, of hCG from the
trophoblast.
In summary, CRISP-3 is expressed in the decidualized endometrium
of pregnancy and is higher in tubal ectopic pregnancy. Its inverse
relationship with serum hCG concentrations and the inhibition of
CRISP-3 by hCG in vitro suggests that it may be directly inhibited by
the conceptus. This may have a role in the control of innate immunity
during implantation.
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